Clinical Trial Update: Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of carfilzomib with irinotecan in irinotecan-sensitive cancers and small cell lung cancer has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Camptosar (irinotecan)
• Kyprolis (carfilzomib)

Snippet

Sponsor: Cancer Research and Biostatistics Clinical Trials Consortium | Conditions: Small Cell Lung Carcinoma, Non Small Cell Lung Carcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-09